title: Iron but not folic acid supplementation reduces the risk of low birthweight in pregnant women without anaemia: a case-control study.
abstract: OBJECTIVE
  To assess whether iron and folic acid supplementation reduce the risk of low birthweight (LBW) in women without anaemia.
  
  
  METHODS
  Case-control study.
  
  
  METHODS
  University Hospital of Cantabria.
  
  
  METHODS
  Cases were 322 mothers without anaemia delivering a singleton infant of less than 2500 g. Controls were 934 mothers without anaemia delivering a term non-small-for-gestational-age infant.
  
  
  METHODS
  Data on iron and folic acid supplementation were obtained from prenatal chart record and personal interview. Data on risk factors for LBW were also gathered.
  
  
  RESULTS
  Agreement between the two sources of information was good (82% for folic acid and 94% for iron). Odds ratios yielded from the two sources were very close. Folic acid only (15 mg/day) was unrelated to LBW, whereas iron supplementation (80 mg ferrous sulphate) was associated with a lower risk of LBW (odds ratio (OR) 0.58, 95% CI 0.34 to 0.98), adjusted for smoking, maternal education, body mass index, obstetric diseases during pregnancy, weight gain during pregnancy, and previous LBW. The results of iron plus folic acid were similar to those for iron (OR 0.56, 95% CI 0.33 to 0.96). There was a significant trend towards a lower risk of LBW (p<0.001) with the duration of iron supplementation. After stratifying by the type of LBW, the trend was also significant for any kind of LBW.
  
  
  CONCLUSIONS
  Iron supplementation is associated with a lower risk of LBW in pregnant women without anaemia.
authors.affiliation: Division of Preventive Medicine and Public Health, University of Jaen, 23071 Jaen, Spain.
authors.forename: S
authors.initials: S
authors.lastname: Palma
authors.forename: R
authors.initials: R
authors.lastname: Perez-Iglesias
authors.forename: D
authors.initials: D
authors.lastname: Prieto
authors.forename: R
authors.initials: R
authors.lastname: Pardo
authors.forename: J
authors.initials: J
authors.lastname: Llorca
authors.forename: M
authors.initials: M
authors.lastname: Delgado-Rodriguez
mesh_terms: D000328:Adult; D000740:Anemia; D001724:Birth Weight / Q000187:drug effects; D016022:Case-Control Studies; D016640:Diabetes, Gestational; D019587:Dietary Supplements; D005260:Female; D005317:Fetal Growth Retardation / Q000517:prevention & control*; D005492:Folic Acid / Q000627:therapeutic use*; D006801:Humans; D007230:Infant, Low Birth Weight; D007231:Infant, Newborn; D019266:Iron, Dietary / Q000627:therapeutic use*; D011225:Pre-Eclampsia / Q000517:prevention & control; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic; D011256:Pregnancy Outcome; D011295:Prenatal Care / Q000379:methods; D039401:Prenatal Nutritional Physiological Phenomena; D018570:Risk Assessment
chemical_list: D019266:Iron, Dietary; D005492:Folic Acid